In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations. [PDF]
Steimer A +15 more
europepmc +1 more source
Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis. [PDF]
Cui R +7 more
europepmc +1 more source
Clinical Characteristics and Predictors of Primary Non-Response to Biologic Therapy in Rheumatoid Arthritis and Axial Spondyloarthritis. [PDF]
Beke KS +6 more
europepmc +1 more source
Incidence, baseline-associated factors and burden of difficult-to-manage axial spondyloarthritis: a 10-year analysis of the DESIR cohort. [PDF]
Fakih O +4 more
europepmc +1 more source
The CALLY Index May Reflect Systemic Inflammatory Burden Rather than Patient-Reported Disease Activity in Ankylosing Spondylitis: A Medical Record-Based Cross-Sectional Study. [PDF]
Güner A +3 more
europepmc +1 more source
Association of inflammation and serum adipocytokines with depression and anxiety burden in axial spondyloarthritis. [PDF]
Hušáková M +8 more
europepmc +1 more source
Prevalence and clinical factors associated with difficult-to-manage axial spondyloarthritis: a multicentre Italian cohort study with meta-analysis. [PDF]
Forte G +13 more
europepmc +1 more source
Sex differences in long-term functional deterioration and permanent disability in spondyloarthritis: a 17-year follow-up from the REGISPON-3 study. [PDF]
Moldovan DMM +10 more
europepmc +1 more source
Effects of neuroinflammation and neurotrophic factors on mental health of people with axial spondyloarthritis. [PDF]
Hušáková M +10 more
europepmc +1 more source
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry. [PDF]
Bachmann M +18 more
europepmc +1 more source

